Award,contract · Find a Tender
CDMO for EMBED 3.0 Research Study
Part of CDMO for EMBED 3.0 Research Study.
Due to the highly specific technical requirements regarding product manufacture (microinjection-moulding (MIM) of formulations containing API) it rapidly became clear that we needed to separate the production from the clinical trial services and identify separate vendors for these services. At the current stage of the program, the identification and selection of a Contract Development and Manufacturing Organization (CDMO) was prioritized by the EMBED team and the funder.
- Procurement
- CDMO for EMBED 3.0 Research Study
- Buyer
- Cardiff University
- Published
- 27 Apr 2026
- Status
- complete
- CPV
- —
- Tender period
- —
Awards
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 27 Apr 2026.
Which procurement does this notice belong to?
It is part of "CDMO for EMBED 3.0 Research Study", published by Cardiff University.
Has this notice resulted in an award?
1 award is recorded on this notice, including to ProMed Pharma, LLC.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable